Search research articles
Contact Us
Filters
Showing results (1391-1400 of 1,442) with videos related to
Page
of 145
Sort By:
Journal of Medicinal Chemistry
|
August 14, 2008
Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities
Dehui Duan, Dina M Sigano, James A Kelley, et al.
Nature
|
June 11, 2025
Early life high fructose impairs microglial phagocytosis and neurodevelopment
Zhaoquan Wang, Allie Lipshutz, Celia Martínez de la Torre, et al.
Nature Medicine
|
January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Cell
|
December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 17, 2023
Climate change, human health, and resilience in the Holocene
Gwen Robbins Schug, Jane E Buikstra, Sharon N DeWitte, et al.
Genes
|
January 21, 2023
Exome Array Analysis of 9721 Ischemic Stroke Cases from the SiGN Consortium
Huichun Xu, Kevin Nguyen, Brady J Gaynor, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor
Kim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2020
De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population
Michael D Kessler, Douglas P Loesch, James A Perry, et al.
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Page
of 145
Search research articles
Search
Showing results (1391-1400 of 1,442) with videos related to
Sort By:
Page
of 145
Journal of Medicinal Chemistry
|
August 14, 2008
Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities
Dehui Duan, Dina M Sigano, James A Kelley, et al.
Nature
|
June 11, 2025
Early life high fructose impairs microglial phagocytosis and neurodevelopment
Zhaoquan Wang, Allie Lipshutz, Celia Martínez de la Torre, et al.
Nature Medicine
|
January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M Varghese, Maria A Perry, Joanne F Chou, et al.
Cancer Cell
|
December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 17, 2023
Climate change, human health, and resilience in the Holocene
Gwen Robbins Schug, Jane E Buikstra, Sharon N DeWitte, et al.
Genes
|
January 21, 2023
Exome Array Analysis of 9721 Ischemic Stroke Cases from the SiGN Consortium
Huichun Xu, Kevin Nguyen, Brady J Gaynor, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor
Kim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2020
De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population
Michael D Kessler, Douglas P Loesch, James A Perry, et al.
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Page
of 145